XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total
Balance at Dec. 31, 2022         $ 91,469
Balance (in shares) at Dec. 31, 2022         4,939,946
Balance at Dec. 31, 2023         $ 91,469
Balance (in shares) at Dec. 31, 2023         4,939,946
Balance at Dec. 31, 2022 $ 1 $ 1,153 $ (97,059) $ 28 $ (95,877)
Balance (in shares) at Dec. 31, 2022 756,160        
Increase (Decrease) in Stockholders' Deficit          
Foreign currency translation adjustment       (11) (11)
Stock option exercises   13     13
Stock option exercises (in shares) 23,748        
Stock-based compensation   442     442
Net loss     (36,590)   (36,590)
Balance at Dec. 31, 2023 $ 1 1,608 (133,649) 17 $ (132,023)
Balance (in shares) at Dec. 31, 2023 779,908       786,510
Increase (Decrease) in Stockholders' Deficit          
Financial Designation, Predecessor and Successor [Fixed List]         Predecessor
Exchange preferred stock for pre-funded warrants         $ (4,686)
Exchange preferred stock for pre-funded warrants (shares)         (207,902,000)
Balance at Jul. 30, 2024         $ 86,783
Balance (in shares) at Jul. 30, 2024         4,732,044
Increase (Decrease) in Stockholders' Deficit          
Foreign currency translation adjustment       3 $ 3
Exchange preferred stock for pre-funded warrants   4,332     4,332
Stock option exercises   9     $ 9
Stock option exercises (in shares) 305       0
Stock-based compensation   642     $ 642
Net loss     (21,278)   (21,278)
Balance at Jul. 30, 2024 $ 1 6,591 (154,927) 20 $ (148,315)
Balance (in shares) at Jul. 30, 2024 780,213        
Increase (Decrease) in Stockholders' Deficit          
Financial Designation, Predecessor and Successor [Fixed List]         Predecessor
Balance at Dec. 31, 2023         $ 91,469
Balance (in shares) at Dec. 31, 2023         4,939,946
Balance at Dec. 31, 2023 $ 1 1,608 (133,649) 17 $ (132,023)
Balance (in shares) at Dec. 31, 2023 779,908       786,510
Increase (Decrease) in Stockholders' Deficit          
Issuance of earn-out shares (in shares)         1,147,500
Balance at Dec. 31, 2024 $ 2 90,495 (70,586) 1 $ 19,912
Balance (in shares) at Dec. 31, 2024 15,198,232       15,198,232
Balance at Jul. 30, 2024         $ 86,783
Balance (in shares) at Jul. 30, 2024         4,732,044
Balance at Jul. 30, 2024 $ 1 6,591 (154,927) 20 $ (148,315)
Balance (in shares) at Jul. 30, 2024 780,213        
Increase (Decrease) in Stockholders' Deficit          
Foreign currency translation adjustment         1
Net loss         (53,763)
Balance at Dec. 31, 2024 $ 2 90,495 (70,586) 1 $ 19,912
Balance (in shares) at Dec. 31, 2024 15,198,232       15,198,232
Increase (Decrease) in Stockholders' Deficit          
Financial Designation, Predecessor and Successor [Fixed List]         Successor
Balance at Jul. 31, 2024 $ 1 89,786 (16,823)   $ 72,964
Balance (in shares) at Jul. 31, 2024 13,387,636        
Increase (Decrease) in Stockholders' Deficit          
Foreign currency translation adjustment       1 1
Exercise of pre-funded warrants $ 1 709     710
Exercise of pre-funded warrants (in shares) 663,096        
Issuance of earn-out shares (in shares) 1,147,500        
Net loss     (53,763)   (53,763)
Balance at Dec. 31, 2024 $ 2 $ 90,495 $ (70,586) $ 1 $ 19,912
Balance (in shares) at Dec. 31, 2024 15,198,232       15,198,232